The latest closing stock price for Kalaris Therapeutics as of April 25, 2025 is 6.70.
An investor who bought $1,000 worth of Kalaris Therapeutics stock at the IPO in 2020 would have $-989 today, roughly -1 times their original investment - a -59.08% compound annual growth rate over 5 years.
The all-time high Kalaris Therapeutics stock closing price was 1076.63 on December 04, 2020.
The Kalaris Therapeutics 52-week high stock price is 24.14, which is 260.3% above the current share price.
The Kalaris Therapeutics 52-week low stock price is 5.87, which is 12.4% below the current share price.
The average Kalaris Therapeutics stock price for the last 52 weeks is 14.30.